- Associated Press - Monday, March 12, 2012

In a story Feb. 24 about weight loss drugs and a story March 8 about Orexigen Therapeutics Inc.’s quarterly earnings, The Associated Press inaccurately described the ingredients in Orexigen’s drug Contrave. The pill combines bupropion, the active ingredient in the antidepressant Wellbutrin, with the anti-addiction drug naltrexone. Naltrexone is not the active ingredient in Wellbutrin.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide